The Prognostic Impact of Neoadjuvant Chemoradiotherapy on Lymph Node Sampling in Patients with Locally Advanced Rectal Cancer

Overview

Journal Updates Surg

Specialty General Surgery

Date 2020 Jul 8

PMID 32632764

Citations 3

Authors

Giovanni Li Destri

Andrea Maugeri

Alice Ramistella

Gaetano La Greca

Pietro Conti

Giovanni Trombatore

Giada Maria Vecchio

Gaetano Giuseppe Magro

Martina Barchitta

Antonella Agodi

Affiliations

Soon will be listed here.

Abstract

According to the American Joint Committee on Cancer, at least 12 lymph nodes are required to accurately stage locally advanced rectal cancer (LARC). Neoadjuvant chemoradiation therapy (NACRT) reduces the number of lymph nodes retrieved during surgery. In this study, we evaluated the effect of NACRT on lymph node retrieval and prognosis in patients with LARC. We performed an observational study of 142 patients with LARC. Although our analysis was retrospective, data were collected prospectively. Half the patients were treated with NACRT and total mesorectal excision (TME) and the other half underwent TME only. The number of lymph nodes retrieved and the number of metastatic lymph nodes were significantly reduced in the NACRT group (P > 0.001). In the univariate and multivariate analyses, only NACRT and patient age were significantly associated with reduced lymph node retrieval. The number of metastatic lymph nodes and the lymph node ratio (LNR) both had a significant effect on prognosis when the patient population was examined as a whole (P = 0.003 and P = 0.001, respectively). However, the LNR was the only significant, independent prognostic factor in both treatment groups (P = 0.007 for the NACRT group; P = 0.04 for the no-NACRT group). NACRT improves patient prognosis only when the number of metastatic lymph nodes is reduced. The number of metastatic lymph nodes and the LNR are important prognostic factors. Lymph node retrieval remains an indispensable tool for staging and prognostic assessment of patients with rectal carcinoma treated with NACRT.

Citing Articles

Log odds of positive nodes as a prognostic factor for rectal cancer: a retrospective study.

Yavuz A, Buyukkasap C, Altiner S, Kurtoglu B, Koyuncuoglu C, Gobut H Rev Assoc Med Bras (1992). 2024; 70(2):e20230417.

PMID: 38198298 PMC: 10768676. DOI: 10.1590/1806-9282.2023417.

Epigenetic Aging and Colorectal Cancer: State of the Art and Perspectives for Future Research.

Maugeri A, Barchitta M, Magnano San Lio R, Li Destri G, Agodi A, Basile G Int J Mol Sci. 2020; 22(1).

PMID: 33379143 PMC: 7795459. DOI: 10.3390/ijms22010200.

Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy.

Wei F, Mei S, Chen J, Wang Z, Shen H, Li J World J Gastroenterol. 2020; 26(42):6638-6657.

PMID: 33268952 PMC: 7673964. DOI: 10.3748/wjg.v26.i42.6638.

References

Shwaartz C, Haim N, Rosin D, Lawrence Y, Gutman M, Zmora O . Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response. Colorectal Dis. 2015; 17(7):595-9. DOI: 10.1111/codi.12902. View

Zhang C, Li Y, Zhang Q, Biondi A, Fico V, Persiani R . The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer. Front Oncol. 2019; 8:628. PMC: 6305371. DOI: 10.3389/fonc.2018.00628. View

Li Destri G, Di Carlo I, Scilletta R, Scilletta B, Puleo S . Colorectal cancer and lymph nodes: the obsession with the number 12. World J Gastroenterol. 2014; 20(8):1951-60. PMC: 3934465. DOI: 10.3748/wjg.v20.i8.1951. View

Li Destri G, Barchitta M, Pesce A, Latteri S, Bosco D, Di Cataldo A . Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients. J Invest Surg. 2017; 32(1):1-7. DOI: 10.1080/08941939.2017.1369605. View

Wu Z, Qin G, Zhao N, Jia H, Zheng X . A statistical tool for risk assessment as a function of the number of lymph nodes retrieved from rectal cancer patients. Colorectal Dis. 2018; 20(8):O199-O206. DOI: 10.1111/codi.14264. View

Loftas P, Arbman G, Fomichov V, Hallbook O . Nodal involvement in luminal complete response after neoadjuvant treatment for rectal cancer. Eur J Surg Oncol. 2016; 42(6):801-7. DOI: 10.1016/j.ejso.2016.03.013. View

Koo T, Song C, Kim J, Kim K, Chie E, Kang S . Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy. PLoS One. 2015; 10(9):e0138728. PMC: 4575157. DOI: 10.1371/journal.pone.0138728. View

He Y, Bian H, Xia T, Zhuo Z, Lu H, Wang Z . Effect of neoadjuvant radiotherapy on lymph node ratio of rectal cancer patients: An ordinal logistic regression analysis. Eur J Surg Oncol. 2016; 42(8):1249-51. DOI: 10.1016/j.ejso.2016.03.028. View

Ceelen W, Willaert W, Varewyck M, Libbrecht S, Goetghebeur E, Pattyn P . Effect of Neoadjuvant Radiation Dose and Schedule on Nodal Count and Its Prognostic Impact in Stage II-III Rectal Cancer. Ann Surg Oncol. 2016; 23(12):3899-3906. DOI: 10.1245/s10434-016-5363-4. View

10.

Hanley J, McNeil B . The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143(1):29-36. DOI: 10.1148/radiology.143.1.7063747. View

11.

Bhatti A, Akbar A, Hafeez A, Syed A, Khattak S, Jamshed A . Impact of lymph node ratio and number on survival in patients with rectal adenocarcinoma after preoperative chemo radiation. Int J Surg. 2014; 13:65-70. DOI: 10.1016/j.ijsu.2014.11.038. View

12.

Dworak O, Keilholz L, Hoffmann A . Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997; 12(1):19-23. DOI: 10.1007/s003840050072. View

13.

Couch D, Hemingway D . Complete radiotherapy response in rectal cancer: A review of the evidence. World J Gastroenterol. 2016; 22(2):467-70. PMC: 4716052. DOI: 10.3748/wjg.v22.i2.467. View

14.

Pei J, Zhang C, Fan Y, Dai D . Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer. Front Oncol. 2019; 8:671. PMC: 6340930. DOI: 10.3389/fonc.2018.00671. View

15.

Scarinci A, DI Cesare T, Cavaniglia D, Neri T, Colletti M, Cosenza G . The impact of log odds of positive lymph nodes (LODDS) in colon and rectal cancer patient stratification: a single-center analysis of 323 patients. Updates Surg. 2018; 70(1):23-31. PMC: 7590807. DOI: 10.1007/s13304-018-0519-3. View

16.

Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R . Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351(17):1731-40. DOI: 10.1056/NEJMoa040694. View

17.

Berho M, Oviedo M, Stone E, Chen C, Nogueras J, Weiss E . The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer. Colorectal Dis. 2008; 11(3):254-8. DOI: 10.1111/j.1463-1318.2008.01597.x. View

18.

Gurawalia J, Dev K, Nayak S, Kurpad V, Pandey A . Less than 12 lymph nodes in the surgical specimen after neoadjuvant chemo-radiotherapy: an indicator of tumor regression in locally advanced rectal cancer?. J Gastrointest Oncol. 2017; 7(6):946-957. PMC: 5177569. DOI: 10.21037/jgo.2016.09.03. View

19.

Jin C, Deng X, Li Y, He W, Yang X, Liu J . Lymph node ratio is an independent prognostic factor for rectal cancer after neoadjuvant therapy: A meta-analysis. J Evid Based Med. 2018; 11(3):169-175. DOI: 10.1111/jebm.12289. View

20.

Kreis M, Maurer C, Ruppert R, Ptok H, Strassburg J, Junginger T . [Lymph node dissection after primary surgery and neoadjuvant radiochemotherapy of rectal cancer. Interim analysis of a multicenter prospective observational study (OCUM)]. Chirurg. 2015; 86(12):1132-7. DOI: 10.1007/s00104-015-0062-4. View